<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00849641</url>
  </required_header>
  <id_info>
    <org_study_id>UR-ST9201/09</org_study_id>
    <nct_id>NCT00849641</nct_id>
  </id_info>
  <brief_title>Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis</brief_title>
  <official_title>Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Regensburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Regensburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with decompensated liver cirrhosis exhibit numerous hemodynamic and microvascular
      changes, i.e., low systemic blood pressure and peripheral vasodilatation. In addition,
      alterations of tissue oxygenation are described in these patients.

      Near-infrared spectroscopy (NIRS) has been proposed as a tool to quantify microvascular
      dysfunction, for example in patients with sepsis (1) or after trauma (2). NIRS is a
      non-invasive technique that uses the differential absorption properties of oxygenated and
      desoxygenated hemoglobin to evaluate skeletal muscle oxygenation (3).

      Up to the investigators' knowledge no data exist on NIRS measurements in patients with
      decompensated liver cirrhosis.

      Aims of this study are to evaluate:

        -  Are there any changes in NIRS parameters in patients with decompensated liver cirrhosis
           in comparison to other critically ill patients (matched to SAPS II Score) or healthy
           individuals?

        -  Is there a correlation with common accepted prognostic scores (MELD Score or indocyanin
           green clearance) in decompensated liver cirrhosis patients and initial NIRS parameters?

        -  Does the NIRS trend within the first three days of ICU care in decompensated liver
           cirrhosis patients receiving fluid replacement therapy correlate with the course of
           disease?

             1. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow
                is altered in patients with sepsis. Am J Respir Crit Care Med. 2002 Jul
                1;166(1):98-104.

             2. Creteur J. Muscle StO2 in critically ill patients. Curr Opin Crit Care. 2008
                Jun;14(3):361-6.

             3. Creteur J, Carollo T, Soldati G, Buchele G, De Backer D, Vincent JL. The prognostic
                value of muscle StO2 in septic patients. Intensive Care Med. 2007
                Sep;33(9):1549-56.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients fulfilling inclusion criteria and without exclusion criteria will be monitored by
      NIRS using InSpectra™ technology (Hutchinson, USA) for the first three days of their ICU
      hospitalization. Besides registration of the NIRS parameters (tissue hemoglobin saturation
      (StO2), total tissue hemoglobin (THI), dynamic test values by using occlusion testing)
      baseline characteristics (age, sex, SAPS II Score et.), disease relevant information
      (etiology of liver cirrhosis, cause of ICU hospitalization) and ICU data (catecholamine
      therapy, mechanical ventilation, hemodynamic monitoring, fluid therapy) will be recorded.
      Within the observation time, an indocyanin green-clearance measurement and further laboratory
      testing will be performed on a daily basis. Data will be pseudonymized and kept confidential
      according to the guidelines of the local ethics committee.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">March 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>patients with decompensated liver cirrhosis admitted to the medical ICU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>critically ill patients without liver cirrhosis, matched to group 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>healthy control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with decompensated liver cirrhosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with decompensated liver cirrhosis admitted to the medical ICU

          -  written informed consent signed by the patients or his/her closest family member

          -  age ≥ 18year

        Exclusion Criteria:

          -  no written informed consent signed by the patients or his/her closest family member
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvia Siebig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Regensburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sylvia Siebig, MD</last_name>
    <phone>+49 941 944</phone>
    <phone_ext>7010</phone_ext>
    <email>sylvia.siebig@klinik.uni-regensburg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93042</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvia Siebig, MD</last_name>
      <phone>+49 941 944</phone>
      <phone_ext>7010</phone_ext>
      <email>sylvia.siebig@klinik.uni-regensburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Christian E Wrede, MD</last_name>
      <phone>+49 941 944</phone>
      <phone_ext>7010</phone_ext>
      <email>christian.wrede@klinik.uni-regensburg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2009</study_first_submitted>
  <study_first_submitted_qc>February 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2009</study_first_posted>
  <last_update_submitted>February 20, 2009</last_update_submitted>
  <last_update_submitted_qc>February 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Sylvia Siebig, MD</name_title>
    <organization>University of Regensburg, Germany</organization>
  </responsible_party>
  <keyword>decompensation</keyword>
  <keyword>septic shock</keyword>
  <keyword>tissue oxygenation</keyword>
  <keyword>near infrared spectroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

